BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1582 related articles for article (PubMed ID: 27959632)

  • 1. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.
    Affo S; Yu LX; Schwabe RF
    Annu Rev Pathol; 2017 Jan; 12():153-186. PubMed ID: 27959632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.
    Baglieri J; Brenner DA; Kisseleva T
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis.
    Filliol A; Schwabe RF
    Semin Liver Dis; 2019 Jul; 39(3):315-333. PubMed ID: 31226725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?
    Kang N; Shah VH; Urrutia R
    Mol Cancer Res; 2015 Apr; 13(4):604-12. PubMed ID: 25548101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.
    Liu J; Chen S; Wang W; Ning BF; Chen F; Shen W; Ding J; Chen W; Xie WF; Zhang X
    Cancer Lett; 2016 Aug; 379(1):49-59. PubMed ID: 27216982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease.
    Okabe H; Hayashi H; Nakagawa S; Imai K; Nitta H; Arima K; Hashimoto D; Chikamoto A; Ishiko T; Beppu T; Baba H
    Histol Histopathol; 2016 Feb; 31(2):141-8. PubMed ID: 26398776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
    Carloni V; Luong TV; Rombouts K
    Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts in hepatocellular carcinoma.
    Kubo N; Araki K; Kuwano H; Shirabe K
    World J Gastroenterol; 2016 Aug; 22(30):6841-50. PubMed ID: 27570421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma.
    Tschumperlin DJ; Lagares D
    Pharmacol Ther; 2020 Aug; 212():107575. PubMed ID: 32437826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer associated fibroblasts: is the force the path to the dark side?
    Barbazán J; Matic Vignjevic D
    Curr Opin Cell Biol; 2019 Feb; 56():71-79. PubMed ID: 30308331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling.
    Lau EY; Lo J; Cheng BY; Ma MK; Lee JM; Ng JK; Chai S; Lin CH; Tsang SY; Ma S; Ng IO; Lee TK
    Cell Rep; 2016 May; 15(6):1175-89. PubMed ID: 27134167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug targeting to myofibroblasts: Implications for fibrosis and cancer.
    Yazdani S; Bansal R; Prakash J
    Adv Drug Deliv Rev; 2017 Nov; 121():101-116. PubMed ID: 28720422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
    Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
    Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment.
    Chung JY; Chan MK; Li JS; Chan AS; Tang PC; Leung KT; To KF; Lan HY; Tang PM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts.
    Heits N; Heinze T; Bernsmeier A; Kerber J; Hauser C; Becker T; Kalthoff H; Egberts JH; Braun F
    BMC Cancer; 2016 May; 16():322. PubMed ID: 27206490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
    Sazeides C; Le A
    Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of microRNAs in cancer associated fibroblasts of gastric cancer.
    Yan Y; Wang R; Guan W; Qiao M; Wang L
    Pathol Res Pract; 2017 Jul; 213(7):730-736. PubMed ID: 28554761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.
    Lugo R; Gabasa M; Andriani F; Puig M; Facchinetti F; Ramírez J; Gómez-Caro A; Pastorino U; Fuster G; Almendros I; Gascón P; Davalos A; Reguart N; Roz L; Alcaraz J
    Oncotarget; 2016 Dec; 7(50):82324-82337. PubMed ID: 27384989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.